Where Are You in the Pharmaceutical Innovation Race?

Overview:

"The ability to learn faster than your competitors may be the only sustainable competitive advantage." —Arie De Geus (as quoted in The Fifth Discipline by Peter Senge) Scientific innovation within pharmaceutical companies is still treated as an inherently unstructured and unmanageable process. Therefore, much pharmaceutical R&D is too reliant upon informal, unconnected, and highly customized personal productivity tools such as email, spreadsheets, and homegrown software tools. These approaches do not facilitate the modern approach to pharmaceutical development the industry needs to bring profitable products to market more quickly. Complete the registration form and download the white paper in PDF format.

"The ability to learn faster than your competitors may be the only sustainable competitive advantage." —Arie De Geus (as quoted in The Fifth Discipline by Peter Senge)

 

Scientific innovation within pharmaceutical companies is still treated as an inherently unstructured and unmanageable process. Therefore, much pharmaceutical R&D is too reliant upon informal, unconnected, and highly customized personal productivity tools such as email, spreadsheets, and homegrown software tools. These approaches do not facilitate the modern approach to pharmaceutical development the industry needs to bring profitable products to market more quickly. 

 

Complete the registration form and download the white paper in PDF format.

Author: Accelrys

Find more white papers on Operational Excellence & Lean Six Sigma

View all white papers»